HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $97 | -66.7% | 64,528 | -44.6% | 0.01% | -72.2% |
| Q4 2022 | $291 | -99.9% | 116,574 | +34.8% | 0.04% | -25.0% |
| Q3 2022 | $365,000 | -35.1% | 86,459 | -57.1% | 0.05% | -42.9% |
| Q2 2022 | $562,000 | -33.7% | 201,424 | +35.8% | 0.08% | -26.3% |
| Q1 2022 | $848,000 | +170.1% | 148,272 | +331.3% | 0.11% | +192.3% |
| Q4 2021 | $314,000 | -19.5% | 34,374 | -5.7% | 0.04% | -2.5% |
| Q3 2021 | $390,000 | -58.2% | 36,442 | -39.4% | 0.04% | -61.9% |
| Q2 2021 | $933,000 | +72.5% | 60,093 | +80.1% | 0.10% | +16.7% |
| Q1 2021 | $541,000 | -13.4% | 33,369 | -20.9% | 0.09% | -13.5% |
| Q3 2020 | $625,000 | +31.6% | 42,177 | +4.2% | 0.10% | -12.6% |
| Q1 2020 | $475,000 | -26.7% | 40,459 | +46.8% | 0.12% | +58.7% |
| Q4 2019 | $648,000 | – | 27,559 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |